top line data

Validive Received a Fast Track Designation for Prevention and Treatment of Oral Mucositis
Jan 26, 2014
BioAlliance Pharma, an innovative Company dedicated to the development of orphan oncology, announced today that Validive (clonidine Lauriad) received a Fast Track designation from the US Food and Drug Administration (FDA) for the prevention ...

Tags: FDA, BioAlliance Pharma, disease, Validive
Patient Enrollment Was Completed by Venaxis in Appy1 Test Trial
Jan 26, 2014
Venaxis, a US-based in vitro diagnostic firm, has completed the patient enrollment in its pivotal clinical study of the APPY1 test in the US. The APPY1 test, a unique appendicitis test, has projected high sensitivity and negative ...

Tags: Venaxis, APPY1, Steve Lundy, FDA
Keryx Biopharmaceuticals Has Reported a Net Loss of $5.47m for The Third Quarter
Nov 29, 2012
Keryx Biopharmaceuticals has reported a net loss of $5.47m, or $0.08 per share, for the third quarter ended 30 September 2012 compared to a net loss of $10.25m, or $0.15 per share, for the third quarter ended 30 September 2011. Operating ...

Tags: Net Loss, Biopharmaceuticals, top-line data